{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$4.92 vs. cons $4.84",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Medical Care Ratio (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~88.2% vs. cons 88.5% (lower ratio = favorable, ~30bps better)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$110.3B vs. cons $110.7B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Adjusted EPS guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$18.35 vs. cons $18.32 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Medical Care Ratio guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~88.5% vs. cons 88.6% (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Optum Health FY2026 operating margin trajectory",
      "prediction": "BETTER",
      "answer": "guide ~4.5% vs. cons 4.0% (FY2026, en route to 6-8% long-term target)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "Stock is up ~30% YTD and ~13% off June lows heading into print with a ~6% implied move and analyst targets already lifted to $460-480, meaning a modest EPS beat/in-line MCR is largely priced in ('sell-the-news' risk). Q1's Optum Health beat was flagged by CFO DeVeydt as partly favorable prior-year reserve development, not a clean run-rate; if Q2 similarly leans on non-recurring items or reiterates (rather than raises) the FY18.25+ floor, sell-side models will likely trim H2/out-year Optum Insight and Optum Rx ramp assumptions (currently ~60% H2-weighted) even after a headline beat, since the 2/3 H1 / 1/3 H2 cadence math leaves little room for upside surprise in the back half. Continued DOJ overhang and Medicaid margin drag reinforce a fade rather than follow-through.",
  "day5_confidence": "MEDIUM"
}